Fc fragment of IgG binding protein suppresses tumor growth by stabilizing wild type P53 in colorectal cancer cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Fc fragment of IgG binding protein (FCGBP) is downregulated in colorectal cancer (CRC), inhibiting tumor growth by stabilizing P53. This discovery offers a new therapeutic target for CRC treatment.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Fc fragment of IgG binding protein (FCGBP) shows varied expression in tumors, but its function in cancer is unclear.
- Colorectal cancer (CRC) progression and prognosis require further understanding of molecular mechanisms.
Purpose Of The Study
- To investigate the role of FCGBP in colorectal cancer (CRC) progression.
- To elucidate the underlying molecular mechanism of FCGBP's function in CRC.
Main Methods
- Differential gene expression analysis in CRC.
- In vitro and in vivo cell growth assays.
- Immunoprecipitation to study protein-protein interactions.
Main Results
- FCGBP is downregulated in CRC and linked to poor prognosis.
- FCGBP overexpression suppresses P53 wild-type CRC cell growth.
- FCGBP competitively binds MDM2, reducing P53 ubiquitination and stabilizing P53.
Conclusions
- FCGBP acts as a tumor suppressor in CRC by stabilizing P53.
- FCGBP downregulation is associated with adverse CRC outcomes.
- FCGBP represents a potential therapeutic target for CRC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...